### **Product Description: OB-Cal Tablet**
**OB-Cal Tablet** is a **calcium and vitamin D supplement** formulated to support **bone health, teeth strength, and overall skeletal development**. It is ideal for individuals at risk of **calcium deficiency, osteoporosis, or bone-related issues**, helping maintain **strong bones and healthy teeth**.
—
### **How OB-Cal Tablet Works**
OB-Cal Tablet provides a **combination of essential nutrients**:
* **Calcium** supports **bone density, teeth strength, and skeletal health**
* **Vitamin D3** enhances **calcium absorption** and promotes **healthy bone metabolism**
* Contributes to **muscle function and overall metabolic health**
Regular supplementation ensures **strong, healthy bones and teeth** while reducing the risk of **calcium deficiency-related conditions**.
—
### **Benefits of OB-Cal Tablet**
* Strengthens **bones and teeth**
* Supports **healthy calcium metabolism**
* Helps prevent **osteoporosis and bone-related disorders**
* Enhances **muscle function and physical strength**
* Suitable for **adults, adolescents, and individuals at risk of calcium deficiency**
—
### **Directions for Use**
Take **OB-Cal Tablet** as advised by your doctor, usually **once or twice daily**, preferably **after meals** with water. Do not exceed the recommended dose.
—
### **Possible Side Effects**
* Mild stomach upset or constipation
* Nausea (rare)
* Allergic reactions (very rare)
Consult your doctor if any side effects persist or worsen.
—
### **Safety Advice**
* **Pregnancy & Breastfeeding:** Safe under medical supervision
* **Kidney or Heart Conditions:** Consult a doctor before use
* **Other Medications:** Inform your healthcare provider about other supplements or medications
* **Storage:** Store in a **cool, dry place**, away from sunlight and moisture
—
### **Product Variants & Keywords**
OB-Cal Tablet, OB-Cal Calcium & Vitamin D Tablet, OB-Cal Bone Health Tablet, OB-Cal Osteoporosis Prevention, OB-Cal Skeletal Strength Tablet, OB-Cal Nutritional Supplement
Reviews
There are no reviews yet.